Teladoc Health, Inc.

For the period ended Dec 31, 2025. Filed Feb 26, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 26, 2026

TDOC$8.98+2.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(in thousands, except share and per share data)

	December 31,2025	December 31,2024
ASSETS
Current assets:
Cash and cash equivalents	$781,084	$1,298,327
Accounts receivable, net of allowance for doubtful accounts of $4,033 and $5,134 at December 31, 2025 and December 31, 2024, respectively	192,826	214,146
Inventories	38,203	38,138
Prepaid expenses and other current assets	107,016	113,296
Total current assets	1,119,129	1,663,907
Property and equipment, net	26,972	29,487
Goodwill	283,190	283,190
Intangible assets, net	1,297,087	1,431,360
Operating lease—right-of-use assets	26,119	27,092
Other assets	105,803	81,488
Total assets	$2,858,300	$3,516,524
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$47,967	$33,130
Accrued expenses and other current liabilities	198,208	202,157
Accrued compensation	96,258	76,229
Deferred revenue—current	62,305	79,296
Convertible senior notes, net—current	—	550,723
Total current liabilities	404,738	941,535
Other liabilities	643	720
Operating lease liabilities, net of current portion	34,204	32,135
Deferred revenue, net of current portion	9,139	9,786
Deferred taxes, net	28,945	49,851
Convertible senior notes, net—non-current	994,925	991,418
Total liabilities	1,472,594	2,025,445
Commitments and contingencies (Note 18)
Stockholders’ equity:
Common stock, $0.001 par value; 300,000,000 shares authorized; 178,315,400 shares and 173,405,016 shares issued and outstanding as of December 31, 2025 and December 31, 2024 respectively	178	173
Additional paid-in capital	17,850,478	17,759,194
Accumulated deficit	(16,430,222)	(16,229,900)
Accumulated other comprehensive loss	(34,728)	(38,388)
Total stockholders’ equity	1,385,706	1,491,079
Total liabilities and stockholders’ equity	$2,858,300	$3,516,524

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.